Cardiovascular pharmacotherapeutics
Author(s)
Bibliographic Information
Cardiovascular pharmacotherapeutics
McGraw-Hill, Medical Pub. division, c2003-c2004
2nd ed
- v. 1 : McGraw-Hill ed
- v. 2 : McGraw-Hill ed
- manual
Available at / 2 libraries
-
v. 1 : McGraw-Hill ed493.23/C/100346953,
v. 2 : McGraw-Hill ed493.23/C/200346954, manual493.23/C/ベ00347453 OPAC
-
No Libraries matched.
- Remove all filters.
Note
Includes bibliographies and index in each vol
Manual (xi, 802 p. ; 21 cm)
Description and Table of Contents
Description
This portable reference provides current, on-the-spot information on how to use every approved cardiovascular medication in adults and children, and the scientific rationale for their use. A clinical distillation of the editors' comprehensive and highly respected Cardiovascular Therapeutics textbook - this totally revised, treatment-centered manual features: indications, contraindications, dosage, side effects, pharmacokinetics, and adverse reactions for all approved cardiovascular drugs, including the latest therapeutic agents; rationales and usage guidelines for therapeutic strategies; abundant tables and charts that summarize important clinical choices; handy appendices that quickly provide guidance on special considerations - pregnancy, renal insufficiency, hepatic disease and/or congestive heart failure, the elderly, ethnic issues, and more; and, considerations for managing patients on multi-drug regimens.New to this edition are: the latest anticoagulants, thrombolytics, antihypertensives, antiarrhythmics, and cholesterol-lowering drugs; innovative therapies for treating hypertension, angina, MI, peripheral vascular disease, and more; new treatment guidelines reflecting the most recent clinical trials; and, use of alternative/complementary medicine (herbals, vitamins, fish oil, hormones).
Table of Contents
1. Basic Principles of Clinical Pharmacology Relevant to Cardiology2. Alpha- and Beta-Adrenergic Blocking Drugs3. Cholinergic and Anticholinergic Drugs4. Calcium Channel Blockers5. The Renin-Angiotensin Axis: Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers6. Diuretic Therapy in Cardiovascular Disease7. Magnesium, Potassium, and Calcium as Potential Cardiovascular Disease Therapies8. Inotropic Agents9. The Organic Nitrates and Nitroprusside10. Antiadrenergic Drugs with Central Action and Neuron Depeletors11. Nonspecific Antihypertensive Vasodilators12. Antiarrhythmic Drugs13. Antiplatelets and Antithrombotic Drugs14. Thrombolytic Agents15. Lipid-Lowering Drugs16. Combination Drug Therapy17. Selective and Nonselective Dopamine-Receptor Agonists18. Use of Prostacyclin and its Analogues in the Treatment of Pulmonary Hypertension and Other Cardiovascular Diseases19. Natriuretic and Other Vasoactive Peptides20. Endothelin as a Therapeutic Target in the Treatment of Cardiovascular DiseaseSpecial Topics Section21. Cardiovascular Drug Interactions22. Drug Treatment of Peripheral Vascular Disease23. Use of Alternative/Complementary Medicine in Treating Cardiovascular Disease24. Pediatric Cardiovascular Pharmacology25. Infective EndocarditisAppendix 1. Pharmacokinetic Properties of Approved Cardiovascular DrugsAppendix 2. Therapeutic Use of Available Cardiovascular DrugsAppendix 3. Guide to Cardiovascular Drug Use in Pregnancy and with NursingAppendix 4. Dosing Recommendations of Cardiovascular Drugs in Patients with Hepatic Disease and/or Congestive Heart FailureAppendix 5. Dose Adjustment in Patients with Renal InsufficiencyAppendix 6. Selected Cardiovascular Medications and Gender IssuesAppendix 7. Pharmacokinetic Changes, Route of Elimination, and Dosage Adjustment of Selected Cardiovascular Drugs in the ElderlyAppendix 8. Selected Cardiovascular Medications and Ethnic Issues
by "Nielsen BookData"